Tools and criteria to select patients with advanced Parkinson's disease for device-aided therapies: a narrative review
HR Moes, T Henriksen, J Sławek… - Journal of Neural …, 2023 - Springer
This article provides an overview of the various screening and selection tools which have
been developed over the past 25 years to identify patients with Parkinson's disease (PD) …
been developed over the past 25 years to identify patients with Parkinson's disease (PD) …
Advanced therapies in Parkinson's disease: an individualized approach to their indication
Device aided therapies (DAT) comprising the intrajejunal administration of
levodopa/carbidopa intestinal gel (LCIG) and levodopa/carbidopa/entacapone intestinal gel …
levodopa/carbidopa intestinal gel (LCIG) and levodopa/carbidopa/entacapone intestinal gel …
Synergien statt Rivalitäten–die missverstandenen Rollen von kontinuierlicher intrajejunaler Levodopatherapie und Tiefer Hirnstimulation in der Behandlung des …
In der Therapie des Morbus Parkinson kommen sowohl die intrajejunale Applikation von
Levodopa/Carbidopa Intenstinalgel (LCIG) und seit kurzem Levodpoa/Carbidopa …
Levodopa/Carbidopa Intenstinalgel (LCIG) und seit kurzem Levodpoa/Carbidopa …
[引用][C] Radiofrequency Ablation: How to Ensure Worldwide Availability of Surgery for Parkinson's Disease
M Merello, M Hariz - Movement Disorders Clinical Practice, 2023 - Wiley Online Library
This article provides an overview of a presentation at the 2nd Movement Disorders Clinical
Practice (MDCP) conference, which focused on the unequal global availability of advanced …
Practice (MDCP) conference, which focused on the unequal global availability of advanced …